Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Brain Neoplasms 2 Sarcoma 1 Pituitary Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Hodgkin Disease 1 Glioma 1 Fatigue 1 Cytokine Release Syndrome 1 Astrocytoma 1

Interventions

Cyclophosphamide 16 fludarabine phosphate 13 Peripheral Blood Stem Cell Transplantation 13 Whole-Body Irradiation 10 Cyclosporine 10 Antilymphocyte Serum 9 Melphalan 8 Busulfan 8 Mycophenolic Acid 7 Filgrastim 6 fludarabine 5 Radiotherapy 5 Methotrexate 5 Etoposide 5 Psychiatric Rehabilitation 4 Methylprednisolone 4 Cytarabine 4 Carmustine 4 Blood Specimen Collection 4 thymoglobulin 3 Therapeutics 3 Rituximab 3 Flow Cytometry 3 Aprepitant 3 Analgesia 3 Tacrolimus 2 Stem Cell Transplantation 2 Proton Therapy 2 Polymerase Chain Reaction 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hodgkin Disease × Neuropsychological Tests × Clear all

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡